Drug information for RIVASTIGMINE TARTRATE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CAPSULE; ORAL
EQ 1.5MG BASE
Prescription
AB
RIVASTIGMINE TARTRATE
rivastigmine
WATSON LABS
77129
CAPSULE; ORAL
EQ 3MG BASE
Prescription
AB
RIVASTIGMINE TARTRATE
rivastigmine
WATSON LABS
"
CAPSULE; ORAL
EQ 4.5MG BASE
Prescription
AB
RIVASTIGMINE TARTRATE
rivastigmine
WATSON LABS
"
CAPSULE; ORAL
EQ 6MG BASE
Prescription
AB
RIVASTIGMINE TARTRATE
rivastigmine
WATSON LABS
"
CAPSULE; ORAL
EQ 1.5MG BASE
Prescription
AB
RIVASTIGMINE TARTRATE
rivastigmine
DR REDDYS LABS INC
77130
2007-11-08 Letter
CAPSULE; ORAL
EQ 3MG BASE
Prescription
AB
RIVASTIGMINE TARTRATE
rivastigmine
DR REDDYS LABS INC
"
CAPSULE; ORAL
EQ 4.5MG BASE
Prescription
AB
RIVASTIGMINE TARTRATE
rivastigmine
DR REDDYS LABS INC
"
CAPSULE; ORAL
EQ 6MG BASE
Prescription
AB
RIVASTIGMINE TARTRATE
rivastigmine
DR REDDYS LABS INC
"
CAPSULE; ORAL
EQ 1.5MG BASE
Prescription
AB
RIVASTIGMINE TARTRATE
rivastigmine
SUN PHARM INDS
77131
2007-10-25 Letter
CAPSULE; ORAL
EQ 3MG BASE
Prescription
AB
RIVASTIGMINE TARTRATE
rivastigmine
SUN PHARM INDS
"
CAPSULE; ORAL
EQ 4.5MG BASE
Prescription
AB
RIVASTIGMINE TARTRATE
rivastigmine
SUN PHARM INDS
"
CAPSULE; ORAL
EQ 6MG BASE
Prescription
AB
RIVASTIGMINE TARTRATE
rivastigmine
SUN PHARM INDS
"
CAPSULE; ORAL
EQ 1.5MG BASE
Tentative Approval
(Reference Drug)
RIVASTIGMINE TARTRATE
rivastigmine
ORCHID HLTHCARE
90879
CAPSULE; ORAL
EQ 3MG BASE
Tentative Approval
(Reference Drug)
RIVASTIGMINE TARTRATE
rivastigmine
ORCHID HLTHCARE
"
CAPSULE; ORAL
EQ 4.5MG BASE
Tentative Approval
(Reference Drug)
RIVASTIGMINE TARTRATE
rivastigmine
ORCHID HLTHCARE
"
CAPSULE; ORAL
EQ 6MG BASE
Tentative Approval
(Reference Drug)
RIVASTIGMINE TARTRATE
rivastigmine
ORCHID HLTHCARE
"
CAPSULE; ORAL
1.5MG
Tentative Approval
RIVASTIGMINE TARTRATE
rivastigmine
ALEMBIC PHARMS LTD
91689
CAPSULE; ORAL
3MG
Tentative Approval
RIVASTIGMINE TARTRATE
rivastigmine
ALEMBIC PHARMS LTD
"
CAPSULE; ORAL
4.5MG
Tentative Approval
RIVASTIGMINE TARTRATE
rivastigmine
ALEMBIC PHARMS LTD
"
CAPSULE; ORAL
6MG
Tentative Approval
RIVASTIGMINE TARTRATE
rivastigmine
ALEMBIC PHARMS LTD
"
Drug Adverse Effects information for RIVASTIGMINE TARTRATE
Role code
Indications
Reaction
# Reports
PS
CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE
HEART RATE ABNORMAL
1
PS
CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE
SYNCOPE
1
PS
DEMENTIA
HEART RATE ABNORMAL
1
PS
DEMENTIA
SYNCOPE
1
PS
DEMENTIA ALZHEIMER'S TYPE
AKINESIA
1
PS
DEMENTIA ALZHEIMER'S TYPE
CONVULSION
1
PS
DEMENTIA ALZHEIMER'S TYPE
PANIC ATTACK
1
PS
HYPERTENSION
HEART RATE ABNORMAL
1
PS
HYPERTENSION
SYNCOPE
1
PS
PARKINSON'S DISEASE
HEART RATE ABNORMAL
1
PS
PARKINSON'S DISEASE
SYNCOPE
1
SS
CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE
HEART RATE ABNORMAL
1
SS
CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE
SYNCOPE
1
SS
DEMENTIA
HEART RATE ABNORMAL
1
SS
DEMENTIA
SYNCOPE
1
SS
HYPERTENSION
HEART RATE ABNORMAL
1
SS
HYPERTENSION
SYNCOPE
1
SS
PARKINSON'S DISEASE
HEART RATE ABNORMAL
1
SS
PARKINSON'S DISEASE
SYNCOPE
1
C
ANALGESIC THERAPY
BLOOD URINE PRESENT
1
C
ARRHYTHMIA
ANXIETY
1
C
ARRHYTHMIA
CEREBROVASCULAR ACCIDENT
1
C
ARRHYTHMIA
DEMENTIA ALZHEIMER'S TYPE
1
C
ARRHYTHMIA
INCORRECT ROUTE OF DRUG ADMINISTRATION
1
C
ARRHYTHMIA
NERVOUSNESS
1
C
ARRHYTHMIA
WEIGHT INCREASED
1
C
BLOOD CHOLESTEROL
ANXIETY
1
C
BLOOD CHOLESTEROL
CEREBROVASCULAR ACCIDENT
1
C
BLOOD CHOLESTEROL
DEMENTIA ALZHEIMER'S TYPE
1
C
BLOOD CHOLESTEROL
INCORRECT ROUTE OF DRUG ADMINISTRATION
1
C
BLOOD CHOLESTEROL
NERVOUSNESS
1
C
BLOOD CHOLESTEROL
WEIGHT INCREASED
1
C
GASTROINTESTINAL STROMAL TUMOUR
DRUG INEFFECTIVE
2
C
GASTROINTESTINAL STROMAL TUMOUR
GASTROINTESTINAL STROMAL TUMOUR
2
C
GASTROINTESTINAL STROMAL TUMOUR
NEOPLASM MALIGNANT
2
C
GASTROINTESTINAL STROMAL TUMOUR
PELVIC MASS
2
C
GASTROINTESTINAL STROMAL TUMOUR
RENAL CYST
2
C
GASTROINTESTINAL STROMAL TUMOUR
WEIGHT DECREASED
2
C
HYPERTENSION
ACCIDENTAL OVERDOSE
2
C
HYPERTENSION
ANXIETY
3
C
HYPERTENSION
CEREBROVASCULAR ACCIDENT
3
C
HYPERTENSION
DEMENTIA ALZHEIMER'S TYPE
3
C
HYPERTENSION
HYPOTENSION
2
C
HYPERTENSION
INCORRECT ROUTE OF DRUG ADMINISTRATION
3
C
HYPERTENSION
NERVOUSNESS
3
C
HYPERTENSION
WEIGHT INCREASED
3
C
MUSCULOSKELETAL PAIN
ANXIETY
1
C
MUSCULOSKELETAL PAIN
CEREBROVASCULAR ACCIDENT
1
C
MUSCULOSKELETAL PAIN
DEMENTIA ALZHEIMER'S TYPE
1
C
MUSCULOSKELETAL PAIN
INCORRECT ROUTE OF DRUG ADMINISTRATION
1
C
MUSCULOSKELETAL PAIN
NERVOUSNESS
1
C
MUSCULOSKELETAL PAIN
WEIGHT INCREASED
1
C
PARKINSON'S DISEASE
DRUG INEFFECTIVE
4
C
PARKINSON'S DISEASE
GASTROINTESTINAL STROMAL TUMOUR
4
C
PARKINSON'S DISEASE
NEOPLASM MALIGNANT
4
C
PARKINSON'S DISEASE
PELVIC MASS
4
C
PARKINSON'S DISEASE
RENAL CYST
4
C
PARKINSON'S DISEASE
WEIGHT DECREASED
4
C
PRODUCT USED FOR UNKNOWN INDICATION
ANXIETY
8
C
PRODUCT USED FOR UNKNOWN INDICATION
CEREBROVASCULAR ACCIDENT
8
C
PRODUCT USED FOR UNKNOWN INDICATION
DEMENTIA ALZHEIMER'S TYPE
8
C
PRODUCT USED FOR UNKNOWN INDICATION
INCORRECT ROUTE OF DRUG ADMINISTRATION
8
C
PRODUCT USED FOR UNKNOWN INDICATION
NERVOUSNESS
8
C
PRODUCT USED FOR UNKNOWN INDICATION
WEIGHT INCREASED
8
C
RHEUMATOID ARTHRITIS
ANXIETY
1
C
RHEUMATOID ARTHRITIS
CEREBROVASCULAR ACCIDENT
1
C
RHEUMATOID ARTHRITIS
DEMENTIA ALZHEIMER'S TYPE
1
C
RHEUMATOID ARTHRITIS
INCORRECT ROUTE OF DRUG ADMINISTRATION
1
C
RHEUMATOID ARTHRITIS
NERVOUSNESS
1
C
RHEUMATOID ARTHRITIS
WEIGHT INCREASED
1
Ads by Google